Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00909935 · ClinicalTrials.gov registry record
The Pharmacokinetics of Dexmedetomidine in Children
A clinical trial, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- 40
- Enrollment target
NCT00909935: Clinical Trial study, sponsored by Boston Children's Hospital.
NCT00909935 is a clinical trial that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00909935 was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
This study is designed to identify the plasma concentrations which are required to achieve adequate sedation, using a Ramsay Sedation Scale. As an alpha 2 agonist, dexmedetomidine can elicit hemodynamic changes, fluctuations in blood pressure and heart rate. This study will attempt to determine whether these changes can be predicted by plasma concentrations.
Interventions
- DRUG Dexmedetomidine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2011-04 |
| Est. Completion | 2013-08 |
Why NCT00909935 stopped before completion
NCT00909935 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Dexmedetomidine is the first listed.
NCT00909935 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00909935 about?
NCT00909935 is a clinical study titled "The Pharmacokinetics of Dexmedetomidine in Children". This study is designed to identify the plasma concentrations which are required to achieve adequate sedation, using a Ramsay Sedation Scale. As an alpha 2 agonist, dexmedetomidine can elicit hemodynamic changes, fluctuations in blood pressure and heart rate. This study will attempt to determine whet...
What is the current status of trial NCT00909935?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 2011-04. Estimated completion is 2013-08.
What interventions are being tested in trial NCT00909935?
The interventions under investigation include: Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT00909935?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia